Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03378739 · ClinicalTrials.gov registry record

Inova Cardiogenic Shock Registry (INOVA SHOCK)

A clinical trial of Cardiogenic Shock, sponsored by Inova Health Care Services.

Recruiting
Registry status
3,000
Enrollment target
1
Study location

NCT03378739 is a study of Cardiogenic Shock that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 3,000 participants, above the 447-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (571% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03378739, a study of Cardiogenic Shock, is actively recruiting participants, sponsored by Inova Health Care Services.

RECRUITING
Registry status
3,000 participants
Enrollment target
1
Study location

Study Summary

To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.

Conditions Studied

Interventions

  • PROCEDURE Cardiogenic Shock team activation

Study Locations (1)

Virginia

  • Inova Fairfax Hospital - Falls Church

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2018-01-01
Est. Completion 2099-12-31

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT03378739

The ClinicalTrials.gov registry entry for NCT03378739 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 447-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (571% higher). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiogenic Shock appearing as the primary indexed condition, and to 1 intervention - of which Cardiogenic Shock team activation is the first listed.

NCT03378739 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03378739 about?

NCT03378739 is a clinical study titled "Inova Cardiogenic Shock Registry (INOVA SHOCK)". To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after...

What is the current status of trial NCT03378739?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2018-01-01. Estimated completion is 2099-12-31.

What conditions does trial NCT03378739 study?

This clinical trial studies the following conditions: Cardiogenic Shock.

What interventions are being tested in trial NCT03378739?

The interventions under investigation include: Cardiogenic Shock team activation (PROCEDURE).

Who is sponsoring clinical trial NCT03378739?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03378739 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiogenic Shock

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.